Life Sciences / Companies

Aisling Capital

Aisling Capital is a healthcare-focused investment firm that invests in companies developing and commercializing pharmaceutical, biotechnology, medical device, diagnostics and services businesses. Since 2000 the firm has raised over $1.8 billion across four funds and takes an active approach—providing capital and strategic, operational and financial support to portfolio companies across private and public structures.

Industries

biotechnology
health-care
venture-capital-b37d

Nr. of Employees

small (1-50)

Aisling Capital

Aisling Capital 489 5th Avenue 10th Floor New York, NY 10017

Portfolio

Aclaris Therapeutics, Inc.

Year invested: 2016; Company status: public; Investment status: current; Location: Malvern, PA

#Biopharma

Aimmune Therapeutics, Inc.

Year invested: 2015; Company status: public; Investment status: historic; Location: Brisbane, CA

#Biopharma

Loxo Oncology, Inc.

Year invested: 2013; Company status: acquired; Investment status: historic; Location: Stamford, CT

#Biopharma

Quintiles Transnational Holdings Inc.

Year invested: 2003; Company status: public; Investment status: historic; Location: Durham, NC

#Services

Biohaven Pharmaceuticals Ltd.

Year invested: 2016; Company status: public; Investment status: historic; Location: New Haven, CT

#Biopharma

Harmony Biosciences, LLC

Year invested: 2018; Company status: public; Investment status: historic; Location: Plymouth Meeting, PA

#Biopharma

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.